B12
Vitamin B12 studied for energy and metabolic support.
- Status
- Prescription
- Developer
- Isolated 1948 (Folkers/Merck & Smith/Glaxo); crystal structure by Dorothy Hodgkin (1956)
- Receptors / target
- Cofactor for methionine synthase (methylation / folate cycle) and methylmalonyl-CoA mutase (fatty-acid & amino-acid metabolism); not a receptor ligand
- FDA-approved?
- YES
- Prescription available?
- YES
- Studied for
- vitamin B12 deficiency & pernicious anemiamegaloblastic anemiaperipheral neuropathy / subacute combined degenerationhomocysteine / one-carbon metabolismcognition & fatigue (largely negative without deficiency)
Overview
Vitamin B12 (cobalamin) is a cobalt-containing, water-soluble B vitamin and the largest, most complex vitamin known — built around a corrin ring with a central cobalt. It exists in several forms: cyanocobalamin (the stable synthetic form in supplements and the FDA-approved injectable), methylcobalamin and adenosylcobalamin (the active coenzyme forms), and hydroxocobalamin. Humans obtain it almost exclusively from animal foods, and its absorption requires gastric intrinsic factor — the basis of pernicious anemia. Cyanocobalamin injection is an FDA-approved drug for B12 deficiency and pernicious anemia.
Mechanism
B12 is the cofactor for exactly two human reactions. As methylcobalamin it serves methionine synthase, which remethylates homocysteine to methionine — essential for DNA synthesis (by freeing folate) and cellular methylation. As adenosylcobalamin it serves the mitochondrial enzyme methylmalonyl-CoA mutase in the catabolism of odd-chain fatty acids and some amino acids. Deficiency therefore raises homocysteine and methylmalonic acid (useful diagnostic markers) and impairs DNA replication, producing megaloblastic anemia and neurological dysfunction.
Clinical evidence
The case for B12 is firmly established for treating deficiency: repletion corrects megaloblastic anemia and halts (and can partly reverse) neuropathy and spinal-cord degeneration, as detailed in authoritative reviews (NEJM 2013; Nature Reviews Disease Primers 2017). Beyond correcting deficiency the evidence is largely negative — a 2021 systematic review/meta-analysis found B12 supplementation gave no benefit on cognition, depressive symptoms or fatigue in the populations studied. In other words, routine B12 injections in people who are not deficient have little proven benefit.
Safety profile
B12 has an exceptional safety record: it is water-soluble with no established upper intake level, and even large doses are generally very well tolerated, with serious reactions rare. The two notable cautions are hypokalemia during the initial correction of severe megaloblastic anemia (potassium shifts into new cells) and rare hypersensitivity to parenteral cobalamin. Safety rests overwhelmingly on the century-long human record. It is not WADA-prohibited as a substance, though a high-volume IV "drip" can breach WADA's infusion-volume rule. FDA-approved for deficiency; nothing here is treatment or dosing guidance.
- Days 1–14
In genuine B12 deficiency, the hematologic response (reticulocytosis, rising hemoglobin) begins within days to two weeks, and energy/symptoms improve as anemia corrects.
- Weeks to months
Neurological recovery is slower (weeks to months) and may be incomplete if long-standing. In people who are not deficient, injections have little proven benefit.
Reported in published literature and user reports. Not a complete list, and not medical advice.
- Generally very well tolerated; injection-site pain or itching
- Hypokalemia during initial correction of severe megaloblastic anemia
- Rare hypersensitivity / anaphylactoid reactions (parenteral)
- Acneiform eruptions with high-dose use
If severe or unexpected symptoms occur, contact a qualified medical professional. PEPTIDES·INDEX does not provide medical advice.
- Known hypersensitivity to cobalt or to cobalamin (vitamin B12) or any product component
- Leber's hereditary optic neuropathy — B12 (especially cyanocobalamin) can accelerate optic-nerve damage
- Metformin / proton-pump inhibitorsLong-term use can lower B12 absorption/levels
Compare
- vs L-Carnitine
Both are corrective for a deficiency rather than fat-burners; l-carnitine carries a TMAO/cardiovascular flag that B12 does not.
- vs Lipo-B
Lipo-B is a compounded MIC mixture that includes B12; standalone B12 is FDA-approved and far better characterized.
FAQ
Will B12 injections give me more energy?
Only if you are actually deficient. In genuine B12 deficiency, repletion corrects anemia and the fatigue that comes with it. In people with normal B12 levels, a 2021 systematic review found no benefit on fatigue, cognition or mood — the 'energy boost' is not supported by evidence.
Is B12 safe to take?
Yes — B12 has an exceptional safety record. It is water-soluble with no established upper intake level, and even large doses are generally very well tolerated. The main cautions are hypokalemia during the initial correction of severe megaloblastic anemia and rare hypersensitivity to parenteral cobalamin.
Which B12 form is best?
Cyanocobalamin is the stable synthetic form and the FDA-approved injectable; methylcobalamin and adenosylcobalamin are the active coenzyme forms. For correcting deficiency, the injectable forms are all effective; no form has proven superior for non-deficient people.
Is B12 FDA-approved?
Yes. Cyanocobalamin injection is an FDA-approved prescription drug for vitamin B12 deficiency and pernicious anemia — one of the few items in this catalog with full regulatory approval and a century-long human record behind it.
Do injections work better than B12 pills?
For most people, no. High-dose oral B12 is absorbed via a passive route that does not require intrinsic factor and corrects deficiency in many patients. Injections are preferred when absorption is the problem — for example pernicious anemia, severe deficiency or neurological involvement — or when reliable oral intake cannot be assured.
Can I take too much B12?
There is no established tolerable upper intake level, and excess is excreted in urine, so toxicity is very rare. The main exception is Leber's hereditary optic neuropathy, where cyanocobalamin can accelerate optic-nerve damage and should be avoided. This is reference information, not dosing advice.
Similar compounds
Starting references for the library summary. These are not dosing instructions or medical advice.
For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.